All lobbying filings

PROFESSIONAL COMPOUNDING CENTERS OF AMERICA

PROFESSIONAL COMPOUNDING CENTERS OF AMERICA filed a Q1 report for PROFESSIONAL COMPOUNDING CENTERS OF AMERICA on April 21, 2025.

Lobbying for PROFESSIONAL COMPOUNDING CENTERS OF AMERICA

All filings by PROFESSIONAL COMPOUNDING CENTERS OF AMERICA · Everything PROFESSIONAL COMPOUNDING CENTERS OF AMERICA has reported

Filing · LD-2 quarterly report Q1 report

Reporting period

1st Quarter 2025

Jan 1 - Mar 31 · Posted Apr 21, 2025

Expenses

$140,000

What this organization spent lobbying with its own staff. Reported using the LDA's own definitions (method A): the three LDA methods count different costs, so an expenses figure is not comparable across filers that used different ones.

Client based in

Texas

Official filing document

Government bodies contacted 5

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 3

Pharmacy

Issues related to implementation of the Drug Quality and Security Act, issues related to animal drug compounding, issues relating to opioid safety; issues related to the pharmaceutical supply chain; issues related to drug shortages

Medicare/Medicaid

Issues related to Medicare coverage of compounded medications, Drug shortages and Medicare reimbursement for compounded medications, pharmacy direct and indirect remuneration fees

Budget/Appropriations

Agriculture appropriations spending bill; Department of Labor-Health and Human Services appropriations bill

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.